DIN 02506769 — APO-ELTROMBOPAG 50 MG
APO-ELTROMBOPAG is a tablet of Eltrombopag marketed by APOTEX INC. The full Eltrombopag monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02506769
- Brand name
- APO-ELTROMBOPAG
- Active ingredient
- Eltrombopag
- Strength
- 50 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Thrombopoietin receptor agonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Eltrombopag products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02506742 | APO-ELTROMBOPAG | 25 MG | TABLET | APOTEX INC | MARKETED |
| 02361825 | REVOLADE | 25 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 02361833 | REVOLADE | 50 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |